Additive Effects of Orexin B and Vasoactive Intestinal Polypeptide on LL-37-mediated Antimicrobial Activities

Journal of Neuroimmunology - Netherlands
doi 10.1016/j.jneuroim.2010.11.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Vasoactive Intestinal Polypeptide and Cholinergic Mechanisms in Cat Nasal Mucosa: Studies on Choline Acetyltransferase and Release of Vasoactive Intestinal Polypeptide.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1981English

Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Enzymatic Degradation of Helodermin and Vasoactive Intestinal Polypeptide.

Journal of Pharmacobio-Dynamics
1991English

Effects of the Antimicrobial Peptide LL-37 and Hyperthermic Preconditioning in Septic Rats

Anesthesiology
AnesthesiologyPain Medicine
2007English

Interaction of Antimicrobial Peptide Ll-37 With Lipopolysaccharides

Biophysical Journal
Biophysics
2019English

Characterization and Distribution of Molecular Variants of Vasoactive Intestinal Polypeptide

Endocrinologia Japonica
1980English

Effects of Neonatal Alcohol Exposure on Vasoactive Intestinal Polypeptide Neurons in the Rat Suprachiasmatic Nucleus

Alcohol
BiochemistryNeurologyHealthBehavioral NeuroscienceMedicineToxicology
2009English

The Antimicrobial Peptide, LL-37, Inhibits in Vitro Osteoclastogenesis

Journal of Dental Research
Dentistry
2012English

Carbon Monoxide Mediates Vasoactive Intestinal Polypeptide-Associated Nonadrenergic/Noncholinergic Neurotransmission

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy